Abstract:
Mass spectrometry (MS) is powerful in protein discovery and identification. Nevertheless,
accurate MS quantitation of peptides and proteins has challenges due to the fact that the MS
signal fluctuates and the ion signal intensity does not correlate well with the amount of sample.
Typically, popular MS quantitation relies on using isotope-labeling methods which have
associated drawbacks including the need for expensive and time-consuming synthesis of
isotope-labeled peptide, limitation in multiplexing analysis, and non-identical ionization
efficiencies/elution times for heavy and light isotope-labeled peptides during LC/MS run. Herein
we propose a conceptually new approach of using electrochemistry (EC)-assisted mass
spectrometry (MS) for absolute quantitation for both peptides and proteins, without using any
standards or isotope-labeled peptides. It could also allow direct quantitation of modified peptides
such as phosphopeptides and simultaneous quantitation of multiple proteins in a mixture.
In our approach, a target peptide, if containing an electroactive residue (e.g., tyrosine,
cysteine, or tryptophan), is first introduced to an electrochemical cell for electrochemical
oxidation and followed by MS detection. According to Faraday's Law, the total electric charge
(Q), which is responsible for peptide oxidation in coulombs, is proportional to quantity of the
oxidized peptide: Q = nzF, where n is the moles of the oxidized peptide, z is the number of
electrons transferred per molecule during the redox reaction, and F is the Faraday constant
(9.65×104 C/mol). Q can be directly measured from the integration of Faradaic current over time.
The moles of the oxidized peptide can be calculated as n = Q/zF. Meanwhile, the peptide shows
reduced intensity in the acquired MS spectra upon oxidation, and the relative MS intensity
change upon oxidation, ∆i, can reflect the oxidation yield. Thus, the amount of target peptide
converted, in combination with the oxidation yield, can be used to calculate the total amount of
target peptide. Such a strategy is proposed to quantify peptides including those carrying post-
translational modifications (e.g., phosphopeptides, glycopeptides) and proteins (e.g., G-protein
coupled receptor GPCRs and circadian clock proteins) in this proposal.
This method is expected to have significance not only in GPCR-related disease studies
but also help understand the circadian regulation of the gene expression of cyanobacteria. It
would lead to a paradigm shift in quantitative proteomics and prosperous biological applications.